Last reviewed: June 25, 2026
Last updated: June 25, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works through subcutaneous injection—medication delivered into fatty tissue just beneath your skin. Selecting proper injection sites and rotating between locations helps reduce tissue irritation, bruising, and injection-site reactions while maintaining consistent medication absorption. Understanding injection anatomy empowers patients to take control of their personalized weight loss therapy.
Subcutaneous Injection Anatomy and Why Location Matters
Subcutaneous injections target the layer of fatty tissue between skin and muscle, called the hypodermis. This location allows medication to absorb steadily into the bloodstream over time rather than entering muscle or hitting blood vessels directly. Semaglutide requires consistent subcutaneous placement to deliver predictable weekly dosing and minimize adverse reactions. Injecting into areas with sufficient adipose (fat) tissue ensures the medication disperses properly and reduces nerve irritation or bruising.
The absorption rate from subcutaneous fat varies slightly by body region. Abdominal sites typically absorb medication fastest, while thigh and upper-arm injections show slightly slower kinetics. PlexusDx recommends discussing individual absorption patterns with your care team, especially if you notice variable appetite-suppression timing week to week. Proper site selection contributes to the steady state semaglutide achieves after 4–5 weeks of consistent weekly dosing.
Primary Injection Sites: Abdomen, Thigh, and Upper Arm
The abdomen remains the most common injection site for semaglutide because it contains reliable adipose tissue and offers easy access for self-administration. Inject at least two finger-widths away from your navel and avoid any area within one inch of scars, bruises, or tender spots. The outer abdomen (love-handle regions) works well for patients who prefer avoiding the central belly area. Abdominal injections typically show faster medication absorption, which some patients associate with quicker appetite-suppression onset.
The front and outer thighs provide excellent alternative sites with ample subcutaneous fat and fewer nerve endings than the abdomen. Thigh injections cause less discomfort for many patients and work well if abdominal tissue feels tender from rotation. The upper arm (back of the arm, between shoulder and elbow) is less common for self-injection because the tissue layer is thinner, but some patients manage it successfully with proper technique. Rotating between these three primary zones prevents lipohypertrophy—a condition where repeated injections into the same spot thicken or harden surrounding fat tissue.
Rotation Strategy and Preventing Injection Site Complications
Effective site rotation means choosing a different anatomical region each week rather than injecting in slightly different spots within the same area. A simple four-week rotation might use: abdomen week one, right thigh week two, left thigh week three, and upper arm week four. Return to the abdomen week five with a different spot, maintaining at least one-inch spacing from your previous injection location. This pattern ensures each region recovers between injections while preventing the buildup of scar tissue, bruising, or lipodystrophy.
Lipohypertrophy—lumpy, thickened fat deposits from repeated trauma—occurs when patients inject the same spot repeatedly without rotation. Once lipohypertrophy develops, absorption becomes unpredictable and medication may not work as intended. PlexusDx encourages patients to map injection sites on a calendar or use a checklist to ensure true rotation. If you notice bruising, swelling, or hardened tissue, skip that area for at least two weeks and allow time for healing before returning.
Injection Technique, Comfort, and Minimizing Discomfort
Proper injection angle and needle depth determine whether you hit the subcutaneous layer or go too deep into muscle. For most patients, a 45-degree angle works best for abdominal injections, while a 90-degree (perpendicular) angle suits thigh and upper-arm sites. Let the prefilled semaglutide pen rest at room temperature for 30 minutes before injecting; cold medication stings more and absorbs less predictably. Pinching the skin gently at the injection site creates a raised area of fat, reducing the chance of hitting muscle or nerve tissue beneath.
Inject slowly and steadily, taking 3–5 seconds to fully depress the medication pen. Rushing the injection may cause the needle to slip or distribute medication unevenly. Allow 10 seconds after depressing the button before withdrawing the needle, which lets medication fully enter tissue. Some patients find that applying an ice pack 2–3 minutes before injection numbs the site slightly and reduces sting. Rotate needle direction (up, down, left, right) even within the same body region to distribute trauma evenly and prevent localized irritation.
Special Considerations and When to Seek Medical Guidance
Patients with very low body fat or those in advanced stages of weight loss may have fewer suitable injection sites as subcutaneous tissue shrinks. If you approach your goal weight and notice diminished abdominal or thigh adipose tissue, discuss alternative strategies with PlexusDx. Some patients transition to smaller-volume injections or adjust needle length in consultation with their prescriber. Never inject into areas with active inflammation, infection, skin lesions, or recent surgical scars.
Bruising, mild redness, and small bumps typically resolve within 24–48 hours and don't require stopping treatment. However, signs of infection—increasing warmth, spreading redness, pus, or fever—demand immediate medical attention. Persistent lumps, hardening, or significant swelling suggests lipohypertrophy and warrants a conversation with your PlexusDx care team. PlexusDx's compounded semaglutide injection starts at $149 per month and comes with detailed injection guidance and ongoing clinical support to address technique concerns and optimize your therapy experience.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I inject semaglutide into the same spot every week?
No. Repeating injections in the same spot causes lipohypertrophy—thickened, lumpy fat tissue that disrupts medication absorption and may reduce drug effectiveness. Rotate between anatomical regions (abdomen, thighs, upper arms) each week and maintain at least one-inch spacing within each region to prevent complications and maintain consistent dosing.
What is the ideal needle angle for subcutaneous semaglutide injection?
Most subcutaneous injections work best at a 45-degree angle for abdominal sites and 90-degree (perpendicular) angles for thigh and upper-arm injections. Pinching the skin creates a raised fat pocket, ensuring the needle reaches subcutaneous tissue without penetrating muscle. Proper angle and technique maximize comfort and predictable medication absorption.
How much does semaglutide injection cost through PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month with no membership fees or insurance required. Your dose may need to go up as you titrate toward your therapeutic level, but your price won't increase. The medication comes from licensed 503A compounding pharmacies and is HSA/FSA eligible.
Is bruising or mild swelling after semaglutide injection normal?
Minor bruising, redness, and small bumps are normal and typically fade within 24–48 hours. These reactions don't require stopping treatment. However, signs of infection—spreading redness, warmth, pus, or fever—need immediate medical attention. Contact PlexusDx if complications persist beyond 48 hours or worsen.
How does PlexusDx personalize injection therapy?
PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after first month), which maps 14 peptide-pathway mechanisms and 49 peptides to identify genetic variations like GLP1R rs6923761 and MC4R rs17782313. This helps predict individual medication responsiveness and guides whether semaglutide injection, tirzepatide, or combination therapy suits your genetic profile best.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Wegovy Help With Sleep Apnea? Improving Rest Through Weight Loss
Does Wegovy Nausea Go Away? Understanding and Managing Side Effects